Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.

Psychoactive pharmaceuticals are among the most frequently prescribed drugs, contributing to persistent measurable concentrations in aquatic systems. Typically, it is assumed that such contaminants have no human health implications because they exist in extremely low concentrations. We exposed juvenile fathead minnows (Pimephales promelas) to three pharmaceuticals, fluoxetine, venlafaxine and carbamazepine, individually and in a mixture, and measured their effect on the induction of gene expression in fish brains using microarray analysis. Gene expression changes were accompanied by behavioral changes and validated by qPCR analysis. Gene Set Enrichment Analysis was used to perform gene-class analysis of gene expression, testing for enrichment of gene sets known to be involved in human neuronal development, regulation and growth. We found significant enrichment of gene sets for each of the treatments, with the largest induction of expression by the mixture treatment. These results suggest that the psychoactive pharmaceuticals are able to alter expression of fish genes associated with development, regulation and differentiation of synapses, neurons and neurotransmitters. The results provide a new perspective for the consideration of potential consequence for human health due to environmental exposure to unmetabolized psychoactive pharmaceuticals.

[1]  Andrew J. Copp,et al.  Genetics of human neural tube defects , 2009, Human molecular genetics.

[2]  K Kümmerer,et al.  Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. , 2000, Chemosphere.

[3]  K. Swoboda,et al.  Diagnosis and treatment of neurotransmitter-related disorders. , 2002, Neurologic clinics.

[4]  E. Hattori,et al.  Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  A. Sequeira,et al.  Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression , 2009, Molecular Psychiatry.

[6]  Princess E. Osei-Bonsu,et al.  Neural Representation of Object Approach in a Decision-Making Motor Circuit , 2006, The Journal of Neuroscience.

[7]  T. Snell,et al.  Gene Expression Profiling in Ecotoxicology , 2003, Ecotoxicology.

[8]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[9]  C. Richter,et al.  Use of a 15 k gene microarray to determine gene expression changes in response to acute and chronic methylmercury exposure in the fathead minnow Pimephales promelas Rafinesque , 2008 .

[10]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[11]  Vahram Haroutunian,et al.  Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study , 2005, Schizophrenia Research.

[12]  S. Mori,et al.  Postnatal development of locomotor movements in normal and para-chlorophenylalanine-treated newborn rats , 1995, Neuroscience Research.

[13]  Alden K Henderson,et al.  Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. , 2004, The Science of the total environment.

[14]  Jeanne Garric,et al.  Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. , 2008, Toxicology letters.

[15]  Kathryn N North,et al.  The nature and frequency of cognitive deficits in children with neurofibromatosis type 1 , 2005, Neurology.

[16]  S. Watson,et al.  Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia , 2004, Biological Psychiatry.

[17]  G. Griebel,et al.  Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine , 1995, Psychopharmacology.

[18]  Michael Shannon,et al.  The serotonin syndrome. , 2005, The New England journal of medicine.

[19]  G. Gibson Microarrays in ecology and evolution: a preview , 2002, Molecular ecology.

[20]  B. Källén Fluoxetine use in early pregnancy. , 2004, Birth defects research. Part B, Developmental and reproductive toxicology.

[21]  Masanori Seki,et al.  Life‐cycle toxicity of 4‐nonylphenol to medaka (Oryzias latipes) , 2001, Environmental toxicology and chemistry.

[22]  D. Weber Dose-dependent effects of developmental mercury exposure on C-start escape responses of larval zebrafish Danio rerio , 2006 .

[23]  Y. Valcárcel,et al.  Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain). , 2010, Environment international.

[24]  O. Schoor,et al.  Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-κB and Akt Signaling Pathways , 2005, Clinical Cancer Research.

[25]  S. Mori,et al.  Prenatal administration of para-chlorophenylalanine results in suppression of serotonergic system and disturbance of swimming movements in newborn rats , 1998, Neuroscience Research.

[26]  K. Armbrust,et al.  Laboratory persistence and fate of fluoxetine in aquatic environments , 2006, Environmental toxicology and chemistry.

[27]  Reinhard Jahn,et al.  Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution , 1998, Nature.

[28]  B. Källén Neonate characteristics after maternal use of antidepressants in late pregnancy. , 2004, Archives of pediatrics & adolescent medicine.

[29]  T. Jessell Neuronal specification in the spinal cord: inductive signals and transcriptional codes , 2000, Nature Reviews Genetics.

[30]  Mark K. Bennett,et al.  A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion , 1993, Cell.

[31]  J. Lazorchak,et al.  Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. , 2008, Analytical chemistry.

[32]  J. Tarazona,et al.  Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization. , 2010, The Science of the total environment.

[33]  Silvio Morato,et al.  Measuring anxiety in zebrafish: A critical review , 2010, Behavioural Brain Research.

[34]  E. Ayanoglu,et al.  Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[35]  R. Skalko,et al.  Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). , 2007, Neurotoxicology and teratology.

[36]  David N. Reznick,et al.  Do faster starts increase the probability of evading predators , 2005 .

[37]  Giorgio Valle,et al.  The Gene Ontology in 2010: extensions and refinements , 2009, Nucleic Acids Res..

[38]  C. Delerue-Matos,et al.  Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. , 2010, Journal of hazardous materials.

[39]  F. Lohoff Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disorders. , 2010, Methods in molecular biology.

[40]  V. Cunningham,et al.  Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. , 2009, Regulatory toxicology and pharmacology : RTP.

[41]  R. C. Eaton,et al.  The Mauthner cell and other identified neurons of the brainstem escape network of fish , 2001, Progress in Neurobiology.

[42]  Kriston L. McGary,et al.  Systematic discovery of nonobvious human disease models through orthologous phenotypes , 2010, Proceedings of the National Academy of Sciences.

[43]  S. Offermanns,et al.  The semaphorin 4D‐plexin‐B signalLing complex regulates dendritic and axonal complexity in developing neurons via diverse pathways , 2009, The European journal of neuroscience.

[44]  Heuiju Chun,et al.  A generalized false discovery rate in microarray studies , 2011, Comput. Stat. Data Anal..

[45]  G. Vallortigara,et al.  Complementary left and right eye use during predator inspection and shoal‐mate scrutiny in minnows , 2002 .

[46]  Zaharie Moldovan,et al.  Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania , 2009, Environmental science and pollution research international.

[47]  C. Tyler,et al.  Pharmaceuticals in the aquatic environment: A critical review of the evidence for health effects in fish , 2010, Critical reviews in toxicology.

[48]  C. Metcalfe,et al.  Pharmaceuticals and Endocrine Disruptors in Wastewater Treatment Effluents and in the Water Supply System of Calgary, Alberta, Canada , 2006 .

[49]  Robert Gerlai,et al.  Zebrafish antipredatory responses: A future for translational research? , 2010, Behavioural Brain Research.

[50]  S. Jørgensen,et al.  Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.

[51]  G. Vallortigara Comparative Neuropsychology of the Dual Brain: A Stroll through Animals' Left and Right Perceptual Worlds , 2000, Brain and Language.

[52]  D. Guilloteau,et al.  Fetal exposure to teratogens: Evidence of genes involved in autism , 2011, Neuroscience & Biobehavioral Reviews.

[53]  E. Furlong,et al.  Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. , 2008, Analytical chemistry.

[54]  K. Jones,et al.  Birth outcomes in pregnant women taking fluoxetine. , 1996, The New England journal of medicine.

[55]  Michael A. Thomas,et al.  Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organism , 2011, BMC Genomics.

[56]  H. Hoyme,et al.  Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.

[57]  Terje Sagvolden,et al.  A comparison of molecular alterations in environmental and genetic rat models of ADHD: A pilot study , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[58]  C. Barthélémy,et al.  Association study of the NF1 gene and autistic disorder. , 1999, American journal of medical genetics.

[59]  T. Jessell,et al.  A Homeodomain Protein Code Specifies Progenitor Cell Identity and Neuronal Fate in the Ventral Neural Tube , 2000, Cell.

[60]  R. Gerlai,et al.  Acute and chronic alcohol dose: population differences in behavior and neurochemistry of zebrafish , 2009, Genes, brain, and behavior.

[61]  John Struger,et al.  Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada , 2003, Environmental toxicology and chemistry.

[62]  D. Barceló,et al.  Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment , 2008 .

[63]  Alejandro J. Ramirez,et al.  Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. , 2007, Chemosphere.

[64]  D. Barceló,et al.  Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. , 2010, Environment international.

[65]  P. Mecocci,et al.  Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease , 2006, Journal of the Neurological Sciences.

[66]  A. Guha,et al.  Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. , 1999, Surgical neurology.

[67]  P. Anderson,et al.  Human pharmaceuticals in US surface waters: a human health risk assessment. , 2005, Regulatory toxicology and pharmacology : RTP.

[68]  R. E. Strauss,et al.  Behavioural lateralization in zebrafish and four related species of minnows (Osteichthyes: Cyprinidae) , 2010, Animal Behaviour.

[69]  Y. Goda,et al.  Mechanisms of Synapse Assembly and Disassembly , 2003, Neuron.

[70]  Michael A. Thomas,et al.  Implications of informatics approaches in ecological research , 2011, Ecol. Informatics.

[71]  N. Singewald,et al.  Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment , 2002, Neuropharmacology.

[72]  K. Shen,et al.  Molecular mechanisms of synaptic specificity , 2010, Molecular and Cellular Neuroscience.

[73]  C. Eap,et al.  Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects , 2004, Journal of psychopharmacology.

[74]  P. Vourc'h,et al.  A functional tetranucleotide (AAAT) polymorphism in an Alu element in the NF1 gene is associated with mental retardation , 2011, Neuroscience Letters.

[75]  L. Barber,et al.  Predator avoidance performance of larval fathead minnows (Pimephales promelas) following short-term exposure to estrogen mixtures. , 2009, Aquatic toxicology.

[76]  Peter J. Brophy,et al.  Mechanisms of axon ensheathment and myelin growth , 2005, Nature Reviews Neuroscience.

[77]  S. Klaine,et al.  Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. , 2008, Aquatic toxicology.

[78]  Jacob Gibs,et al.  Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. , 2007, The Science of the total environment.

[79]  Michael Davis,et al.  Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats , 1997, Biological Psychiatry.

[80]  T. Ternes Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[81]  C. Hiemke,et al.  Pharmacokinetics of selective serotonin reuptake inhibitors. , 2000, Pharmacology & therapeutics.

[82]  J. Fetcho,et al.  Laser Ablations Reveal Functional Relationships of Segmental Hindbrain Neurons in Zebrafish , 1999, Neuron.

[83]  Arnold J. Stromberg,et al.  Statistical implications of pooling RNA samples for microarray experiments , 2003, BMC Bioinform..

[84]  D. Wong,et al.  Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. , 1995, Life sciences.

[85]  W. Antonin,et al.  Crystal structure of the endosomal SNARE complex reveals common structural principles of all SNAREs , 2002, Nature Structural Biology.

[86]  K. Sloman,et al.  The effects of environmental pollutants on complex fish behaviour: integrating behavioural and physiological indicators of toxicity. , 2004, Aquatic toxicology.

[87]  J. Licinio,et al.  Identification of hypothalamic transcripts upregulated by antidepressants. , 1996, Biochemical and biophysical research communications.

[88]  Dae-Hyuk Kweon,et al.  Regulation of neuronal SNARE assembly by the membrane , 2003, Nature Structural Biology.

[89]  P. Jjemba Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. , 2006, Ecotoxicology and environmental safety.

[90]  Giorgio Vallortigara,et al.  Origins of the left & right brain. , 2009, Scientific American.

[91]  Trevor R. Norman,et al.  The treatment of depression with different formulations of venlafaxine: a comparative analysis , 2004, Human psychopharmacology.

[92]  S. Chapoval,et al.  Biology and function of neuroimmune semaphorins 4A and 4D , 2011, Immunologic research.

[93]  B. H. Miller,et al.  Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine , 2008, Neuropsychopharmacology.

[94]  S. Hernández-Díaz,et al.  First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. , 2007, The New England journal of medicine.

[95]  Paolo Domenici,et al.  Escape behaviour of solitary herring (Clupea harengus ) and comparisons with schooling individuals , 1997 .

[96]  C. Maximino,et al.  Pharmacological analysis of zebrafish (Danio rerio) scototaxis , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[97]  S. Snyder,et al.  Toxicological relevance of pharmaceuticals in drinking water. , 2010, Environmental science & technology.

[98]  David R. Colman,et al.  Molecules, maps and synapse specificity , 2001, Nature Reviews Neuroscience.

[99]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[100]  Diana S Aga,et al.  Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks , 2009, Environmental toxicology and chemistry.

[101]  D. Guilloteau,et al.  Behavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism , 2010, Neuroscience Letters.

[102]  Heiko L Schoenfuss,et al.  Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas) , 2009, Environmental toxicology and chemistry.

[103]  C. de Montigny,et al.  Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers , 1999, British journal of pharmacology.

[104]  L. Moens,et al.  Neuropharmaceuticals in the environment: Mianserin‐induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays , 2006, Environmental toxicology and chemistry.

[105]  R. Gerlai,et al.  Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects , 2000, Pharmacology Biochemistry and Behavior.

[106]  J. Santos,et al.  Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds. , 2010, Journal of hazardous materials.

[107]  Anders Baun,et al.  Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges. , 2009, Chemosphere.

[108]  D. Neary,et al.  Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer’s disease, and pathological correlations with genotype , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[109]  Yu-Ming Chang,et al.  Increased action potential firing rates of layer 2/3 pyramidal cells in the prefrontal cortex are significantly related to cognitive performance in aged monkeys. , 2005, Cerebral cortex.

[110]  K. Borowicz,et al.  Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. , 2006, Pharmacological reports : PR.

[111]  G. Augustine,et al.  SNARE proteins and the timing of neurotransmitter release , 1998, Molecular Psychiatry.

[112]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Y. Fujiyoshi,et al.  Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release , 2008, The Journal of cell biology.

[114]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[115]  Dalma Martinović,et al.  Environmental estrogens suppress hormones, behavior, and reproductive fitness in male fathead minnows , 2007, Environmental toxicology and chemistry.

[116]  Kevin Dobbin,et al.  Effects of pooling mRNA in microarray class comparisons , 2004, Bioinform..

[117]  F. Panza,et al.  The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.